ColinJohnMeyerMDMBA
Other MD/DO • Plano, TXChief Research and Development Officer, Reata Pharmaceuticals, Inc.
Dr. Meyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Reata Pharmaceuticals, Inc.
5320 Legacy Drive Plano
Plano, TX 75024Phone+1 972-865-2200- Is this information wrong?
Education & Training
University of Texas Southwestern Medical SchoolClass of 2003
Clinical Trials
- Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 in Patients With Hepatic Dysfunction Start of enrollment: 2007 Apr 30
- Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes Start of enrollment: 2011 Jun 30
- A Single-Dose, Open-Label, Randomized, Food Effect and Blinded, Randomized, Dose Proportionality Study in Healthy Volunteers With Bardoxolone Methyl Start of enrollment: 2011 Oct 31
- Join now to see all
Publications & Presentations
PubMed
- 25 citationsSafety and efficacy of omaveloxolone in patients with mitochondrial myopathy (MOTOR trial).Karen Lindhardt Madsen, Astrid Emilie Buch, Bruce H. Cohen, Marni J. Falk, Angela Goldsberry, Amy Goldstein, Amel Karaa, Mary Kay Koenig, Colleen C. Muraresku, Colin M...> ;Neurology. 2020 Jan 2
- 25 citationsEffect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease.Peter Rossing, Geoffrey A. Block, Melanie P. Chin, Angie Goldsberry, Hiddo J.L. Heerspink, Peter A. McCullough, Colin J. Meyer, David K. Packham, Pablo E. Pergola, Bru...> ;Kidney International. 2019 Oct 1
- 27 citationsBardoxolone methyl analog attenuates proteinuria-induced tubular damage by modulating mitochondrial functionHajime Nagasu, Yuji Sogawa, Kengo Kidokoro, Seiji Itano, Toshiya Yamamoto, Minoru Satoh, Tamaki Sasaki, Takafumi Suzuki, Masayuki Yamamoto, W. Christian Wigley, Joel W...> ;FASEB Journal. 2019 Aug 30
- Join now to see all
Press Mentions
Bob Goeltz Bolts Unity Biotechnology to Become CFO at Arcus Biosciences; John Johnson Tapped for His Latest CEO GigJuly 10th, 2020- Bardoxolone Methyl Improved Kidney Function in Patients with Autosomal Dominant Polycystic Kidney Disease and IgA Nephropathy in the Ongoing Phase 2 Phoenix StudyMay 25th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
